{"disease":{"id":"locally-advanced-or-metastatic-egfrm-non-small-cell-lung-cancer-nsclc","name":"locally advanced or metastatic egfrm non small cell lung cancer nsclc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07058519","title":"A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}